Differential therapy of acute lymphoblastic leukemia (ALL) in adults
β Scribed by Volkova, M.; Kaletin, G.; Tupitsyn, N.; Frenkel, M.; Fleishman, E.
- Book ID
- 122684549
- Publisher
- Elsevier Science
- Year
- 1993
- Tongue
- English
- Weight
- 165 KB
- Volume
- 29
- Category
- Article
- ISSN
- 0959-8049
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## BACKGROUND Much progress has been made in understanding the biology of acute lymphoblastic leukemia (ALL). This has translated into the recognition of several subgroups of ALL and the institution of riskβadapted therapies. New therapies are emerging based on the definition of specif
Thirty-seven adult patients with acute lymphoblastic leukemia were treated with a protocol called HEAV'D including Adriamycin, Vincristine, L-Asparaginase, Cyclophosphamide and Dexamethasone. The complete remission rate was 70 per cent. The median duration of remission was more than 30 months. Patie